LIVEN news and notes Liven Pharma Limited
Liven Pharma Limited (LIVEN) news and notes: the SuperX note and what changed (4 items). The note is written by SuperX’s AI from its own figures. What changed is listed newest first.
What SuperX wrote about LIVEN
The price rose 9.99% on 13 Nov, at the exchange's daily limit, on 3.89 times the usual volume.
Sector median fell 0.2% on 13 Nov; 5 of 15 sector scrips rose and 10 fell. The sector did not cause this move.
Last year the company filed its quarter results on 2 Jan. The next results' period ends 30 Sep.
Written by SuperX’s analyst desk from SuperX’s own figures, from the close of 13 Nov 2026. Each number was checked against those figures. Not advice.
What changed for LIVEN, newest first
- 13 Nov 2026Closed 39.19, +9.99%. Volume 591,477, 4.7 times the average of the 30 sessions before it, 124,862.
- 4 Nov 2026Trend read changed to sideways: above the 50-day average; up 11.9% over 3 months; fell 53.4% from its 1-year peak at worst.
- 2 Nov 2026Results filed on 2 Nov 2026; the figures are not stored yet.
- NextQuarterly results (to 30 Sep 2026) expected 14 Oct 2026 – 13 Nov 2026, a projection. An estimate from the usual timing across the market; this company has no earlier filings on record.
As of the close of 13 Nov 2026. Closes and notices: PSX. Trend read: SuperX, from daily closes. Volume: against the average of the 30 sessions before the last. Next results: an estimate from the usual timing across the market; this company has no earlier filings on record. Not advice.
More on LIVEN
- LIVEN share price and overview
- Pharmaceuticals sector
- MACTER news and notes · Macter International Limited
- HALEON news and notes · Haleon Pakistan Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .